Literature DB >> 7645638

The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus.

H Minkoff1, D N Burns, S Landesman, J Youchah, J J Goedert, R P Nugent, L R Muenz, A D Willoughby.   

Abstract

OBJECTIVE: Intrapartum events may play a role in determining the likelihood of vertical transmission of human immunodeficiency virus-1. Timing and duration of rupture of membranes have been shown to modify transmission risk of other organisms but have not been examined for human immunodeficiency virus. This study was undertaken to assess the relationship between duration of rupture of membranes, maternal immune status, and transmission of human immunodeficiency virus.
METHODS: The Mothers' and Infants' Cohort Study enrolled 207 human immunodeficiency virus-positive women and their infants at five study sites in Brooklyn and the Bronx, New York between January 1986 and January 1991. One hundred twenty-seven woman-infant sets for whom antepartum CD4+ levels were available, the infant's human immunodeficiency virus infection outcome was known, and the duration of ruptured membranes could be determined were included in this analysis.
RESULTS: Thirty of the 127 evaluable infants (24%) were infected. Women with low CD4+ levels (< 20%) were significantly more likely to transmit the virus if rupture of membranes was > or = 4 hours (relative risk 4.53, 95% confidence interval 1.14 to 1.81, p = 0.02). The same association was not observed among women with higher CD4+ levels (relative risk 1.11, 95% confidence interval 0.52 to 2.69, p = 0.69). No association with the duration of labor or mode of delivery was seen.
CONCLUSIONS: In this urban North American cohort women with low CD4+ levels were significantly more likely to transmit human immunodeficiency virus to their offspring if the duration of rupture of membranes was > or = 4 hours.

Entities:  

Mesh:

Year:  1995        PMID: 7645638     DOI: 10.1016/0002-9378(95)90286-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  17 in total

Review 1.  Prevention of perinatal HIV transmission: current status and future developments in anti-retroviral therapy.

Authors:  Athena P Kourtis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Short-term effect of zidovudine on plasma and genital human immunodeficiency virus type 1 and viral turnover in these compartments.

Authors:  Dorothy Mbori-Ngacha; Barbra A Richardson; Julie Overbaugh; Dana DeVange Panteleeff; Ruth Nduati; Matt Steele; Grace John-Stewart
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 3.  Options for prevention of HIV transmission from mother to child, with a focus on developing countries.

Authors:  Louise Kuhn; Ingrid Peterson
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa.

Authors:  Risa M Hoffman; Vivian Black; Karl Technau; Karin Joan van der Merwe; Judith Currier; Ashraf Coovadia; Matthew Chersich
Journal:  J Acquir Immune Defic Syndr       Date:  2010-05-01       Impact factor: 3.731

Review 5.  Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission.

Authors:  Judith A Cook
Journal:  Life Sci       Date:  2011-01-08       Impact factor: 5.037

Review 6.  Mother-to-child transmission of human immunodeficiency virus type 1.

Authors:  G C John; J Kreiss
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

Review 7.  Advances in prevention of mother-to-child HIV transmission: the international perspectives.

Authors:  Chokechai Rongkavilit; Basim I Asmar
Journal:  Indian J Pediatr       Date:  2010-10-16       Impact factor: 1.967

Review 8.  Advances in prevention of mother-to-child HIV transmission.

Authors:  Chokechai Rongkavilit; Basim I Asmar
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

Review 9.  HIV: mother-to-child transmission.

Authors:  Jimmy Volmink; Ben Marais
Journal:  BMJ Clin Evid       Date:  2008-02-05

Review 10.  Prevention and control of HIV/AIDS.

Authors:  Madhu Choudhry; V P Choudhry
Journal:  Indian J Pediatr       Date:  2003-12       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.